What is Myriad Genetics's PP&E (net)?

Myriad Genetics (MYGN) reported PP&E (net) of $111.5M in Q1 2026.

How has Myriad Genetics's PP&E (net) changed year-over-year?

Myriad Genetics's PP&E (net) decreased by 2.2% year-over-year, from $114M to $111.5M.

What is the long-term trend for Myriad Genetics's PP&E (net)?

Over 5 years (2020 to 2025), Myriad Genetics's PP&E (net) has grown at a 22.9% compound annual growth rate (CAGR), from $40.7M to $114M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Myriad Genetics MYGN PP&E (Net)

PP&E (Net) at other companies

Labcorp HoldingsLH

$3.07B-0.8%

Quest DiagnosticsDGX

$2.19B+4.3%

NeoGenomicsNEO

$83.66M-6.6%

VeracyteVCYT

$22.65M+0.5%

Guardant HealthGH

$150.04M+16.0%

Natera, Inc.NTRA

$269.38M+49.3%

Other financials

Income statement

See full

Revenue$200.4M+2.3%

Gross profit$137.6M+2.5%

Operating income-$30.7M-5.9%

Net income-$34.1M-34,000%

EPS (diluted)-$0.36—

Balance sheet

See full

Cash & equivalents$126.0M+24.8%

Total debt$211.5M+34.2%

Total equity$337.4M-52.1%

Total assets$673.7M-33.0%

Cash flow

See full

Operating cash flow-$15.7M+3.7%

CapEx$18.8M+181%

Free cash flow-$19.7M+65.1%

Valuation

See full

Market cap$512.85M+13.1%

Enterprise value$598.35M+17.3%

P/S0.6×+0.1×

Profitability

See full

Gross margin70%0.0pp

Operating margin-46.9%-88.3pp

Net margin-48.2%-72.9pp

FCF margin-17%—

Returns & leverage

See full

Return on equity-76.7%-98.4pp

Debt / equity0.6×+0.4×

Current ratio2.4×+0.5×

Where this comes from

Reported directly by Myriad Genetics in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Myriad Genetics's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Myriad Genetics's PP&E (net)?: Myriad Genetics (MYGN) reported PP&E (net) of $111.5M in Q1 2026.
How has Myriad Genetics's PP&E (net) changed year-over-year?: Myriad Genetics's PP&E (net) decreased by 2.2% year-over-year, from $114M to $111.5M.
What is the long-term trend for Myriad Genetics's PP&E (net)?: Over 5 years (2020 to 2025), Myriad Genetics's PP&E (net) has grown at a 22.9% compound annual growth rate (CAGR), from $40.7M to $114M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.